Marianne P. Allen

Array ( [id] => 3588470 [patent_doc_number] => 05520913 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-28 [patent_title] => 'Tissue plasminogen activator having zymogenic properties' [patent_app_type] => 1 [patent_app_number] => 8/088451 [patent_app_country] => US [patent_app_date] => 1993-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19529 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/520/05520913.pdf [firstpage_image] =>[orig_patent_app_number] => 088451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3430357 [patent_doc_number] => 05455330 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-03 [patent_title] => 'Interleukin-1 antagonist and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/085455 [patent_app_country] => US [patent_app_date] => 1993-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13560 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/455/05455330.pdf [firstpage_image] =>[orig_patent_app_number] => 085455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1561429 [patent_doc_number] => 06362160 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'Immunophilin-binding agents prevent glutamate neurotoxicity associated with vascular stroke and neurodegenerative diseases' [patent_app_type] => B1 [patent_app_number] => 08/082848 [patent_app_country] => US [patent_app_date] => 1993-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 4290 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/362/06362160.pdf [firstpage_image] =>[orig_patent_app_number] => 08082848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4094156 [patent_doc_number] => 06048526 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Monoclonal antibodies reactive with defined regions of the T cell antigen receptor' [patent_app_type] => 1 [patent_app_number] => 8/083408 [patent_app_country] => US [patent_app_date] => 1993-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 31 [patent_no_of_words] => 29809 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048526.pdf [firstpage_image] =>[orig_patent_app_number] => 083408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3055097 [patent_doc_number] => 05356877 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-18 [patent_title] => 'Methods for promoting growth using porcine growth hormone analogs' [patent_app_type] => 1 [patent_app_number] => 8/081501 [patent_app_country] => US [patent_app_date] => 1993-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6855 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/356/05356877.pdf [firstpage_image] =>[orig_patent_app_number] => 081501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808870 [patent_doc_number] => 05811393 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Heparin binding mitogen with homology to epidermal growth factor (EGF)' [patent_app_type] => 1 [patent_app_number] => 8/039364 [patent_app_country] => US [patent_app_date] => 1993-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14581 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811393.pdf [firstpage_image] =>[orig_patent_app_number] => 039364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3063806 [patent_doc_number] => 05352589 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-04 [patent_title] => 'Deletion mutant of basic fibroblast growth factor and production thereof' [patent_app_type] => 1 [patent_app_number] => 8/071046 [patent_app_country] => US [patent_app_date] => 1993-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 6130 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/352/05352589.pdf [firstpage_image] =>[orig_patent_app_number] => 071046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3897889 [patent_doc_number] => 05750659 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Mammalian growth factor' [patent_app_type] => 1 [patent_app_number] => 8/056482 [patent_app_country] => US [patent_app_date] => 1993-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 9304 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750659.pdf [firstpage_image] =>[orig_patent_app_number] => 056482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3448165 [patent_doc_number] => 05387673 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-07 [patent_title] => 'Active fragments of fibroblast growth factor' [patent_app_type] => 1 [patent_app_number] => 8/054650 [patent_app_country] => US [patent_app_date] => 1993-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6973 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/387/05387673.pdf [firstpage_image] =>[orig_patent_app_number] => 054650 [rel_patent_id] =>[rel_patent_doc_number] =>)